ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years

Registos relacionados

• The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years
  Por: Moncrieff, Marc D., et al.
  Publicado em: (2020)
• The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB–IIC Patients—Results After 3 Years
  Por: Deckers, Eric A., et al.
  Publicado em: (2019)
• ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified
  Por: Francken, Anne Brecht, et al.
  Publicado em: (2019)
• The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients—Results after 1 Year
  Por: Damude, Samantha, et al.
  Publicado em: (2016)
• ASO Author Reflections: Improved Perioperative Seroma and Complication Rates Following the Application of a Two-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma
  Por: Moncrieff, Marc, et al.
  Publicado em: (2020)